These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 35165862)

  • 1. Tumor-Associated Macrophages: Reasons to Be Cheerful, Reasons to Be Fearful.
    Szulc-Kielbik I; Kielbik M
    Exp Suppl; 2022; 113():107-140. PubMed ID: 35165862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 3. The Role of Tumor Associated Macrophages (TAMs) in Cancer Progression, Chemoresistance, Angiogenesis and Metastasis - Current Status.
    Dallavalasa S; Beeraka NM; Basavaraju CG; Tulimilli SV; Sadhu SP; Rajesh K; Aliev G; Madhunapantula SV
    Curr Med Chem; 2021; 28(39):8203-8236. PubMed ID: 34303328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
    Gao J; Liang Y; Wang L
    Front Immunol; 2022; 13():888713. PubMed ID: 35844605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomaterials-Involved Tumor-Associated Macrophages' Reprogramming for Antitumor Therapy.
    Li SL; Hou HY; Chu X; Zhu YY; Zhang YJ; Duan MD; Liu J; Liu Y
    ACS Nano; 2024 Mar; 18(11):7769-7795. PubMed ID: 38420949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy.
    Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z
    Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of chemokines in the crosstalk between tumor and tumor-associated macrophages.
    Qin R; Ren W; Ya G; Wang B; He J; Ren S; Jiang L; Zhao S
    Clin Exp Med; 2023 Sep; 23(5):1359-1373. PubMed ID: 36173487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Evasion in Cancer Is Regulated by Tumor-Asociated Macrophages (TAMs): Targeting TAMs.
    Jung M; Bonavida B
    Crit Rev Oncog; 2024; 29(4):1-17. PubMed ID: 38989734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influencing Factors and Significance of Tumor-associated Macrophage Polarization 
in Tumor Microenvironment].
    Ge W; Wu W
    Zhongguo Fei Ai Za Zhi; 2023 Mar; 26(3):228-237. PubMed ID: 37035885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphoinositide 3-kinase/Akt and its related signaling pathways in the regulation of tumor-associated macrophages polarization.
    Yang D; Yang L; Cai J; Li H; Xing Z; Hou Y
    Mol Cell Biochem; 2022 Oct; 477(10):2469-2480. PubMed ID: 35590082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting tumor-associated macrophages in the tumor microenvironment.
    Zhou K; Cheng T; Zhan J; Peng X; Zhang Y; Wen J; Chen X; Ying M
    Oncol Lett; 2020 Nov; 20(5):234. PubMed ID: 32968456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment.
    Li L; Tian Y
    Biomed Pharmacother; 2023 May; 161():114504. PubMed ID: 37002579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer.
    Zhu X; Liang R; Lan T; Ding D; Huang S; Shao J; Zheng Z; Chen T; Huang Y; Liu J; Pathak JL; Wei H; Wei B
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36104099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic studies of tumor-associated macrophage immunotherapy.
    Cao J; Liu C
    Front Immunol; 2024; 15():1476565. PubMed ID: 39403370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of tumor-associated macrophages in tumor immune evasion.
    Huang R; Kang T; Chen S
    J Cancer Res Clin Oncol; 2024 May; 150(5):238. PubMed ID: 38713256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M1
    Garrido-Martin EM; Mellows TWP; Clarke J; Ganesan AP; Wood O; Cazaly A; Seumois G; Chee SJ; Alzetani A; King EV; Hedrick CC; Thomas G; Friedmann PS; Ottensmeier CH; Vijayanand P; Sanchez-Elsner T
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32699181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated macrophages: A sentinel of innate immune system in tumor microenvironment gone haywire.
    Malik S; Sureka N; Ahuja S; Aden D; Zaheer S; Zaheer S
    Cell Biol Int; 2024 Oct; 48(10):1406-1449. PubMed ID: 39054741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor promoting role of anti-tumor macrophages in tumor microenvironment.
    Goswami KK; Ghosh T; Ghosh S; Sarkar M; Bose A; Baral R
    Cell Immunol; 2017 Jun; 316():1-10. PubMed ID: 28433198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated macrophages: an accomplice in solid tumor progression.
    Chen Y; Song Y; Du W; Gong L; Chang H; Zou Z
    J Biomed Sci; 2019 Oct; 26(1):78. PubMed ID: 31629410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.